あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/27 | 2,632 | 2,636 | 2,526 | 2,526 | -156 | -5.8% | 155,700 |
| 2024/06/26 | 2,706 | 2,720 | 2,639 | 2,682 | +26 | +1% | 119,300 |
| 2024/06/25 | 2,600 | 2,660 | 2,570 | 2,656 | +149 | +5.9% | 145,500 |
| 2024/06/24 | 2,500 | 2,530 | 2,475 | 2,507 | +30 | +1.2% | 87,500 |
| 2024/06/21 | 2,447 | 2,480 | 2,440 | 2,477 | +48 | +2% | 103,600 |
| 2024/06/20 | 2,395 | 2,429 | 2,391 | 2,429 | +16 | +0.7% | 38,100 |
| 2024/06/19 | 2,431 | 2,439 | 2,393 | 2,413 | +21 | +0.9% | 49,700 |
| 2024/06/18 | 2,420 | 2,431 | 2,382 | 2,392 | -7 | -0.3% | 61,400 |
| 2024/06/17 | 2,410 | 2,422 | 2,377 | 2,399 | ±0 | ±0% | 52,600 |
| 2024/06/14 | 2,325 | 2,413 | 2,325 | 2,399 | +117 | +5.1% | 100,800 |
| 2024/06/13 | 2,331 | 2,360 | 2,278 | 2,282 | -61 | -2.6% | 50,500 |
| 2024/06/12 | 2,358 | 2,359 | 2,322 | 2,343 | -11 | -0.5% | 41,400 |
| 2024/06/11 | 2,324 | 2,361 | 2,324 | 2,354 | +45 | +1.9% | 44,500 |
| 2024/06/10 | 2,267 | 2,320 | 2,251 | 2,309 | +65 | +2.9% | 33,400 |
| 2024/06/07 | 2,258 | 2,258 | 2,200 | 2,244 | -19 | -0.8% | 53,800 |
| 2024/06/06 | 2,295 | 2,338 | 2,253 | 2,263 | -32 | -1.4% | 25,400 |
| 2024/06/05 | 2,328 | 2,400 | 2,287 | 2,295 | -1 | ±0% | 40,400 |
| 2024/06/04 | 2,327 | 2,338 | 2,290 | 2,296 | -40 | -1.7% | 46,100 |
| 2024/06/03 | 2,388 | 2,406 | 2,336 | 2,336 | -23 | -1% | 38,400 |
| 2024/05/31 | 2,319 | 2,369 | 2,281 | 2,359 | +65 | +2.8% | 45,300 |
| 2024/05/30 | 2,319 | 2,319 | 2,267 | 2,294 | -29 | -1.2% | 48,600 |
| 2024/05/29 | 2,377 | 2,395 | 2,295 | 2,323 | -37 | -1.6% | 64,000 |
| 2024/05/28 | 2,340 | 2,390 | 2,338 | 2,360 | +2 | +0.1% | 50,400 |
| 2024/05/27 | 2,287 | 2,358 | 2,287 | 2,358 | +80 | +3.5% | 56,900 |
| 2024/05/24 | 2,293 | 2,296 | 2,270 | 2,278 | -28 | -1.2% | 21,800 |
| 2024/05/23 | 2,310 | 2,318 | 2,262 | 2,306 | +46 | +2% | 50,400 |
| 2024/05/22 | 2,257 | 2,311 | 2,240 | 2,260 | +3 | +0.1% | 63,100 |
| 2024/05/21 | 2,282 | 2,320 | 2,251 | 2,257 | -27 | -1.2% | 45,400 |
| 2024/05/20 | 2,273 | 2,315 | 2,268 | 2,284 | +7 | +0.3% | 38,200 |
| 2024/05/17 | 2,266 | 2,308 | 2,256 | 2,277 | -25 | -1.1% | 37,000 |
| 2024/05/16 | 2,327 | 2,348 | 2,299 | 2,302 | -39 | -1.7% | 41,200 |
| 2024/05/15 | 2,450 | 2,450 | 2,330 | 2,341 | -103 | -4.2% | 66,400 |
| 2024/05/14 | 2,426 | 2,489 | 2,393 | 2,444 | -32 | -1.3% | 190,900 |
| 2024/05/13 | 2,400 | 2,534 | 2,319 | 2,476 | +393 | +18.9% | 434,200 |
| 2024/05/10 | 2,115 | 2,119 | 2,067 | 2,083 | -19 | -0.9% | 92,400 |
| 2024/05/09 | 2,112 | 2,128 | 2,100 | 2,102 | -15 | -0.7% | 77,300 |
| 2024/05/08 | 2,210 | 2,210 | 2,112 | 2,117 | -113 | -5.1% | 99,200 |
| 2024/05/07 | 2,252 | 2,261 | 2,230 | 2,230 | -37 | -1.6% | 57,600 |
| 2024/05/02 | 2,280 | 2,289 | 2,235 | 2,267 | -27 | -1.2% | 46,900 |
| 2024/05/01 | 2,315 | 2,325 | 2,283 | 2,294 | -35 | -1.5% | 22,500 |
| 2024/04/30 | 2,290 | 2,339 | 2,270 | 2,329 | +69 | +3.1% | 53,300 |
| 2024/04/26 | 2,258 | 2,270 | 2,219 | 2,260 | +2 | +0.1% | 45,100 |
| 2024/04/25 | 2,285 | 2,314 | 2,234 | 2,258 | -5 | -0.2% | 52,100 |
| 2024/04/24 | 2,240 | 2,270 | 2,233 | 2,263 | +24 | +1.1% | 38,400 |
| 2024/04/23 | 2,217 | 2,248 | 2,215 | 2,239 | +17 | +0.8% | 28,800 |
| 2024/04/22 | 2,240 | 2,240 | 2,207 | 2,222 | +15 | +0.7% | 22,100 |
| 2024/04/19 | 2,244 | 2,244 | 2,164 | 2,207 | -45 | -2% | 85,500 |
| 2024/04/18 | 2,220 | 2,273 | 2,203 | 2,252 | +53 | +2.4% | 40,000 |
| 2024/04/17 | 2,275 | 2,275 | 2,163 | 2,199 | -64 | -2.8% | 59,300 |
| 2024/04/16 | 2,283 | 2,313 | 2,249 | 2,263 | -22 | -1% | 64,000 |
101～
150
件表示中 / 894件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| タウンズ | 56,300円 | +4.6% | +6.1% | 4.97% | 9.46倍 | 4.17倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症得意 |
| 生化学 | 81,000円 | +10.5% | +169.1% | 3.70% | 12.81倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
